Detalles de la búsqueda
1.
Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Institutional Analysis from the Central Pancreatic Consortium.
Ann Surg Oncol
; 30(3): 1485-1494, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36316508
2.
Surgical oncology operative experience at a high-volume safety-net hospital during the COVID-19 pandemic.
J Surg Oncol
; 124(7): 983-988, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34291824
3.
Attrition during neoadjuvant chemotherapy for gastric adenocarcinoma is associated with decreased survival: A United States Safety-Net Collaborative analysis.
J Surg Oncol
; 124(8): 1317-1328, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34379324
4.
Surgical Management of the Axilla in Patients with Occult Breast Cancer (cT0 N+) After Neoadjuvant Chemotherapy.
Ann Surg Oncol
; 27(6): 1830-1841, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31989360
5.
ASO Visual Abstract: Racial Disparity in Pathologic Response Following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer-A Multi-institutional Analysis from the Central Pancreatic Consortium.
Ann Surg Oncol
; 30(3): 1498-1499, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36564655
6.
Nationwide Outcomes of Pancreaticoduodenectomy for Pancreatic Malignancies: Center Volume Matters.
Am Surg
; 89(12): 6020-6029, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37310685
7.
Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies.
Cancers (Basel)
; 12(9)2020 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32846967
Resultados
1 -
7
de 7
1
Próxima >
>>